CYP2C19*10/*31 AND Escitalopram response
- Germline classification:
- drug response (1 submission)
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000784004.10
Allele description [Variation Report for CYP2C19*10/*31]
NM_000769.1(CYP2C19):c.680C>T (p.Pro227Leu)
NM_000769.4(CYP2C19):c.232C>T (p.His78Tyr)
Condition(s)
- Name:
- Escitalopram response
- Synonyms:
- Lexapro response
- Identifiers:
- MedGen: CN221264
-
Linaria minutiflora (0)
Nucleotide
-
ENSOGAP00000004563 (0)
Protein
-
PREDICTED: ethylene-responsive transcription factor TINY-like [Musa acuminata su...
PREDICTED: ethylene-responsive transcription factor TINY-like [Musa acuminata subsp. malaccensis]gi|695056453|ref|XP_009416449.1|Protein
-
Pooling (171600)
PMC
-
PHAVU_006G123700g [Phaseolus vulgaris]
PHAVU_006G123700g [Phaseolus vulgaris]Gene ID:18628594Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 10, 2024